4 completed, 1 active not recruiting, 1 unknown. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Active not recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Hypercalciuria: new trials by email Literature Review of Hypercalciuria trials Research Report on Hypercalciuria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1 Encaleret, Standard of Care - Autosomal Dominant Hypocalcemia (ADH) | Phase 3 | Active not recruiting | Calcilytix Therapeutics, Inc., a BridgeBio company | 67 | 2023-01-06 | 2026-07-29 |
| Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers Vitamin D, Placebo - Asthma, Asthma Exacerbations | Phase 3 | Completed | Professor Francine Ducharme | 323 | 2018-10-01 | 2025-06-03 |
| ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study ACTHAR Gel (adrenocorticotropic hormone) - Sarcoidosis, Hypercalcemia Due to Sarcoidosis | Phase 2 / Phase 3 | Unknown | Albany Medical College | 10 | 2015-02-01 | 2015-01-26 |
| HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism open-label PTH(1-84) - Hypoparathyroidism | Phase 3 | Completed | Columbia University | 62 | 2009-12-01 | 2024-07-05 |
| Low Salt Diet in Idiopathic Hypercalciuria Low salt diet, Water therapy alone - Hypercalciuria | Phase 2 / Phase 3 | Completed | University of Parma | 210 | 2005-01-01 | 2009-10-30 |
| Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria potassium citrate, potassium phosphate - Hypercalciuria, Kidney Calculi | Phase 3 | Completed | National Center for Research Resources (NCRR) | 300 | 1995-04-01 | 2005-06-24 |
Nephrolithiasis (3) · Hypercalcemia (2) · Hypocalcemia (2) · Hypoparathyroidism (2) · Nephrocalcinosis (2) · Asthma (1) · Calcium Metabolism Disorders (1) · Glomerulonephritis (1) · Hypercalciuric Hypocalcemia, Familial (1) · Kidney Calculi (1) · Metabolic Diseases (1) · Muscular Diseases (1) · Musculoskeletal Abnormalities (1) · Musculoskeletal Diseases (1)
Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Urological Manifestations (6) · Nutritional and Metabolic Diseases (4) · Water-Electrolyte Imbalance (4) · Calcium Metabolism Disorders (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Metabolic Diseases (3) · Urolithiasis (3) · Urologic Diseases (3) · Calcinosis (2) · Disease Attributes (2)
Adrenocorticotropic Hormone (1) · Cholecalciferol (1) · Diet, Sodium-Restricted (1) · Parathyroid Hormone (1) · Potassium Citrate (1) · Standard of Care (1) · Vitamin D (1) · Water (1) · potassium phosphate (1)
Albany Medical College (1) · Calcilytix Therapeutics, Inc., a BridgeBio company (1) · Columbia University (1) · National Center for Research Resources (NCRR) (1) · Professor Francine Ducharme (1) · University of Parma (1)
United States (3) · Canada (2) · Italy (2) · Australia (1) · Czechia (1) · Denmark (1) · France (1) · Japan (1) · Netherlands (1) · United Kingdom (1)
Charles Y. C. Pak (1) · Francine M Ducharme, MD (1) · John P Bilezikian, MD (1) · Marc A Judson, MD (1)